MIRA INFORM REPORT

 

 

Report Date :

27.11.2007

 

IDENTIFICATION DETAILS

 

Name :

DROGSAN  ILACLARI SANAYI VE TICARET A.S.

 

 

Registered Office :

Oguzlar Mah. 56.Sokak No:7/3 Balgat Ankara

 

 

Country :

Turkey

 

 

Financials (as on) :

31.12.2006

 

 

Date of Incorporation :

18.03.1975

 

 

Com. Reg. No.:

29800

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture and trade of medicine

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear


COMPANY IDENTIFICATION

 

 

NAME

:

DROGSAN  ILACLARI SANAYI VE TICARET A.S.

ADDRESS

:

Head Office: Oguzlar Mah. 56.Sokak No:7/3 Balgat Ankara/Turkey

Factory: Guldarbi Koyu Yumuk mevkii 30. Km. Cubuk Ankara/Turkey

PHONE NUMBER

:

90-312-287 74 10 (2 lines)

90-312-287 74 50-51

FAX NUMBER

:

90-312-287 61 15

 

 

LEGAL STATUS AND HISTORY

 

 

TAX OFFICE/NUMBER

:

Baskent / 3130025020

 

REGISTRATION NUMBER

:

29800

 

REGISTERED OFFICE

:

Ankara Chamber of Commerce

Ankara Chamber of Industry

 

DATE ESTABLISHED

:

18.03.1975

 

LEGAL FORM

:

Joint Stock Company

 

TYPE OF COMPANY

:

Private

 

REGISTERED CAPITAL

:

YTL 5,800,000

 

PAID-IN CAPITAL

:

YTL 5,800,000

 

HISTORY

:

 

 

 

 

Previous Name

: Drogsan Doga Kaynakli Ilac Hammaddeleri Sanayi ve Ticaret A.S.

 

 

Name Changed On

: 19.08.2002 (Commercial Registry Gazette Date/No: 22.08.2002 / 5619)

 

 

Previous Registered Capital

: YTL 750,000

 

 

Regist. Capital Changed on

: 20.06.2005 (Commercial Registry Gazette Date/No: 23.06.2005/6331)

 

 

OWNERSHIP / MANAGEMENT

 

 

SHAREHOLDERS

:

Mustafa Karpuzcu

Nevzat Karpuzcu

Faika Uslu

Emin Karpuzcu

Others

 

SISTER COMPANIES

:

-Nevzat Ecza Deposu  Ticaret ve Sanayi A.S (Trade of medicine)

-Prestij Ecza Deposu Ticaret ve Sanayi A.S. (Trade of medicine)

 

GROUP PARENT COMPANY

 

:

None

BOARD OF DIRECTORS

:

Nevzat Karpuzcu

Mustafa Karpuzcu

Emin Karpuzcu

Faika Uslu

 

Chairman

Vice-chairman

Member

Member

DIRECTORS

:

Mustafa Karpuzcu

Faika Uslu

General Manager

Deputy General Manager

 

 

OPERATIONS

 

 

BUSINESS ACTIVITIES

:

Manufacture and trade of medicine

 

TRADEMARK(S)

:

“Kloroben”, “Oledro” "Klorhex”, “Zefan”, "Minafen”, "Polyod”…

 

NUMBER OF EMPLOYEES

:

310

 

NET SALES

:

YTL 1,309 Thousand

YTL 1,934 Thousand YTL 3,605 Thousand YTL 7,545 Thousand YTL 13,245 Thousand YTL 17,445 Thousand

YTL 22,623 Thousand

YTL 24,396 Thousand

YTL 27,657 Thousand

(1998)

(1999)

(2000)

(2001)

(2002)

(2003)

(2004)

(2005)

(2006)

 

CAPACITY

:

 

(Lt/Yr)

1,725,000

1,725,000

1,725,000

 

(2005)
(2006)
(2007)

IMPORT VALUE

:

USD 1.3 million

USD 1,071,000

USD 2,645,000

USD 2,907,000

USD 810,000

 

(2003)

(2004)

(2005)

(2006)

(1.1.-31.03.2007)

IMPORT COUNTRIES

:

Finland, Italy, Switzerland, China, India, Germany

 

MERCHANDISE IMPORTED

 

:

Intermediary goods, raw materials

EXPORT VALUE

:

USD   61,796

USD   16,257

YTL 109,350

YTL 314,573

YTL 228,097

YTL 311,783

USD 302,000

USD 295,000

YTL 1,024,960

 

(1998)

(1999)

(2000)

(2001)

(2002)

(2003)

(2004)

(2005)

(2006)

 

EXPORT COUNTRIES

 

:

Jordan, Nigeria

MERCHANDISE EXPORTED

 

:

Medical other antibiotics, retail drugs …

PREMISES

:

Head office: “Oguzlar Mah. 56.Sokak No:7/3 Balgat Ankara”. (owned)

 

Factory: “Guldarni Koyu Yumuk mevkii 30. Km.Cubuk Ankara”. (2,968 sqm closed area over a land of 13,455 sqm) (owned)

 

Liaison offices: Izmir (1), Istanbul (2), Adana (1), Samsun (1), Bursa (1), Erzurum (1), Malatya (1), Antalya (1), Adapazari (1), Ankara (1)

 

FIXED CAPITAL INVESTMENTS

:

None

 

 

TREND OF BUSINESS              :           Upwards

COMMERCIAL MORALITY         :           Good

SIZE OF BUSINESS                  :           Large

 

 

FINANCE

 

 

MAIN DEALING BANKERS

:

Garanti Bankasi Cankaya branch in Ankara

T. Is Bankasi Yenisehir branch in Ankara

Denizbank Kurumsal branch in Ankara

Turk Ekonomi Bankasi Kurumsal  branch in Ankara

T.C.Ziraat Bankasi Bulvar branch in Ankara

Akbank Kurumsal branch in Ankara

Yapi Kredi Bankasi Mesrutiyet branch in Ankara

HSBC Kizilay branch in Ankara

Finansbank Ankara branch in Ankara

 

CREDIT FACILITIES

:

The subject company is making active use of credit facilities.

 

PAYMENT BEHAVIOR

:

No complaints have been heard regarding payments from banks.

 

According to the official registries between 01.01.2000-15.10.2007, there are no protested bills and non-paid cheques registered in the former name (Drogsan Doga) or the current name (Drogsan Ilaclari) of the subject company.

 

 

COMMENT ON FINANCIAL POSITION

 

                                                                                                                           

FINANCIAL STRUCTURE (SUFFICENCY OF OWN RESOURCES)

 

Fair

 

As of 31.12.2006

LIQUIDITY

 

Liquidity ratios were in order as of 31.12.2006 but there was an unfavorable gap between the collection and payment periods adversely affecting liquidity.

 

PROFITABILITY

 

Fair

 

In 2006

GAP BETWEEN COLLECTION-PAYMENT

PERIODS

 

Unfavorable

 

In 2006

GENERAL FINANCIAL

POSITION

 

Fair

 

 

 

CREDIT OPINION

 

 

CREDIT OPINION WITHOUT OBLIGATION : We are of the opinion that, a max. credit of EUR 600,000 may be

                                                                     granted to the subject company.

 

 

 

Incr. in producers’ price index

 

Average YTL/$

Average YTL/EUR

Average YTL/GBP

(1998)

54.30 %

0.2657

0.2967

0.4410

(1999)

62.90 %

0.4278

0.4518

0.6843

(2000)

32.70 %

0.6251

0.5774

0.9480

(2001)

88.60 %

1.1991

1.0714

1.7300

(2002)

30.80 %

1.5168

1.3741

2.2001

(2003)

13.90 %

1.5302

1.7141

2.4982

(2004)

13.84 %

1.4266

1.7666

2.6001

(2005)

2.66 %

1.3499

1.6882

2.4623

(2006)

11.58 %

1.4309

1.7987

2.6377

(1.1.-31.03.2007)

1.88 %

1.4068

1.8521

2.7609

(1.1.-31.10.2007)

4.84 %

1.3308

1.7999

2.6527

 


 

 

BALANCE SHEETS

 

 

YTL Thousand

 

 

 

YTL Thousand

 

 

 

YTL Thousand

 

 

 

 

 

31.12.04

 

 

 

31.12.05

 

 

 

31.12.06

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

13.339

 

0,72

 

13.744

 

0,67

 

18.534

 

0,66

 

 

 Cash and Banks

17

 

0,00

 

402

 

0,02

 

409

 

0,01

 

 

 Marketable Securities

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Account Receivable

11.319

 

0,61

 

9.779

 

0,48

 

13.797

 

0,49

 

 

 Other Receivable

16

 

0,00

 

113

 

0,01

 

53

 

0,00

 

 

 Inventories

1.366

 

0,07

 

2.447

 

0,12

 

2.929

 

0,10

 

 

 Advances Given

530

 

0,03

 

153

 

0,01

 

204

 

0,01

 

 

 Other Current Assets

91

 

0,00

 

850

 

0,04

 

1.142

 

0,04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS

5.307

 

0,28

 

6.656

 

0,33

 

9.376

 

0,34

 

 

 Long-term Receivable

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Financial Assets

1.471

 

0,08

 

2.333

 

0,11

 

2.333

 

0,08

 

 

 Tangible Fixed Assets (net)

2.326

 

0,12

 

2.848

 

0,14

 

4.909

 

0,18

 

 

 Intangible Assets

1.510

 

0,08

 

1.475

 

0,07

 

2.134

 

0,08

 

 

 Other Non-Current Assets

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

18.646

 

1,00

 

20.400

 

1,00

 

27.910

 

1,00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

11.018

 

0,59

 

10.692

 

0,52

 

17.776

 

0,64

 

 

 Financial Loans

8.085

 

0,43

 

8.419

 

0,41

 

13.301

 

0,48

 

 

 Accounts Payable

2.238

 

0,12

 

1.677

 

0,08

 

2.819

 

0,10

 

 

 Loans from Shareholders

75

 

0,00

 

250

 

0,01

 

480

 

0,02

 

 

 Other Short-term Payable

62

 

0,00

 

37

 

0,00

 

80

 

0,00

 

 

 Advances from Customers

143

 

0,01

 

9

 

0,00

 

473

 

0,02

 

 

 Taxes Payable

409

 

0,02

 

300

 

0,01

 

623

 

0,02

 

 

 Provisions

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Other Current Liabilities

6

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LONG-TERM LIABILITIES

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Financial Loans

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Long-term Payable

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Loans from Shareholders

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Other Long-term Liabilities

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Provisions

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

7.628

 

0,41

 

9.708

 

0,48

 

10.134

 

0,36

 

 

 Paid-in Capital

725

 

0,04

 

5.800

 

0,28

 

5.800

 

0,21

 

 

 Inflation Adjustment of Capital

4.829

 

0,26

 

0

 

0,00

 

0

 

0,00

 

 

 Reserves

1.509

 

0,08

 

1.828

 

0,09

 

3.046

 

0,11

 

 

 Revaluation Fund

0

 

0,00

 

863

 

0,04

 

863

 

0,03

 

 

 Accumulated Losses(-)

0

 

0,00

 

0

 

0,00

 

0

 

0,00

 

 

 Net Profit (loss)

565

 

0,03

 

1.217

 

0,06

 

425

 

0,02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND EQ.

18.646

 

1,00

 

20.400

 

1,00

 

27.910

 

1,00

 


 

 

INCOME STATEMENTS

 

 

YTL Thousand

 

 

 

YTL Thousand

 

 

 

YTL Thousand

 

 

 

 

 

2004

 

 

 

2005

 

 

 

2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales

22.623

 

1,00

 

24.396

 

1,00

 

27.657

 

1,00

 

 

 Cost of Goods Sold

9.204

 

0,41

 

9.447

 

0,39

 

10.704

 

0,39

 

 

Gross Profit

13.419

 

0,59

 

14.949

 

0,61

 

16.953

 

0,61

 

 

 Operating Expenses

11.041

 

0,49

 

12.225

 

0,50

 

14.436

 

0,52

 

 

Operating Profit

2.378

 

0,11

 

2.724

 

0,11

 

2.517

 

0,09

 

 

 Other Income

448

 

0,02

 

809

 

0,03

 

550

 

0,02

 

 

 Other Expenses

419

 

0,02

 

173

 

0,01

 

302

 

0,01

 

 

 Financial Expenses

1.486

 

0,07

 

1.592

 

0,07

 

2.195

 

0,08

 

 

Profit (loss) Before Tax

921

 

0,04

 

1.768

 

0,07

 

570

 

0,02

 

 

 Tax Payable

356

 

0,02

 

551

 

0,02

 

145

 

0,01

 

 

Net Profit (loss)

565

 

0,02

 

1.217

 

0,05

 

425

 

0,02

 

 

 

FINANCIAL RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2004

 

 

 

2005

 

 

 

2006

 

 

 

 

LIQUIDITY RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Ratio

1,21

 

 

 

1,29

 

 

 

1,04

 

 

 

 

Acid-Test Ratio

1,03

 

 

 

0,96

 

 

 

0,80

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSET STRUCTURE RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory/Total Assets

0,07

 

 

 

0,12

 

 

 

0,10

 

 

 

 

Short-term Receivable/Total Assets

0,61

 

 

 

0,48

 

 

 

0,50

 

 

 

 

Tangible Assets/Total Assets

0,12

 

 

 

0,14

 

 

 

0,18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TURNOVER RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventory Turnover

6,74

 

 

 

3,86

 

 

 

3,65

 

 

 

 

Stockholders' Equity Turnover

2,97

 

 

 

2,51

 

 

 

2,73

 

 

 

 

Asset Turnover

1,21

 

 

 

1,20

 

 

 

0,99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL STRUCTURE

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity/Total Assets

0,41

 

 

 

0,48

 

 

 

0,36

 

 

 

 

Current Liabilities/Total Assets

0,59

 

 

 

0,52

 

 

 

0,64

 

 

 

 

Financial Leverage

0,59

 

 

 

0,52

 

 

 

0,64

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFITABILITY RATIOS

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Profit/Stockholders' Eq.

0,07

 

 

 

0,13

 

 

 

0,04

 

 

 

 

Operating Profit Margin

0,11

 

 

 

0,11

 

 

 

0,09

 

 

 

 

Net Profit Margin

0,02

 

 

 

0,05

 

 

 

0,02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COLLECTION-PAYMENT

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Collection Period (days)

180,12

 

 

 

144,30

 

 

 

179,59

 

 

 

 

Average Payable Period (days)

87,54

 

 

 

63,91

 

 

 

94,81

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions